Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
US Army
Fish and Richardson
Harvard Business School
Federal Trade Commission

Generated: December 12, 2017

DrugPatentWatch Database Preview

Cefaclor - Generic Drug Details

« Back to Dashboard

What are the generic sources for cefaclor and what is the scope of cefaclor freedom to operate?

is the generic ingredient in four branded drugs marketed by Lilly, Ceph Intl, Dava Pharms Inc, Hikma, Ivax Sub Teva Pharms, Ranbaxy, Teva, Watson Labs Inc, Yung Shin Pharm, Facta Farma, Ranbaxy Labs Ltd, and World Gen, and is included in thirty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for cefaclor. Eleven suppliers are listed for this compound.

Pharmacology for cefaclor

Medical Subject Heading (MeSH) Categories for cefaclor

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
LillyCECLOR CDcefaclorTABLET, EXTENDED RELEASE;ORAL050673-001Jun 28, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Dava Pharms IncCEFACLORcefaclorCAPSULE;ORAL064107-002Apr 27, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Dava Pharms IncCEFACLORcefaclorFOR SUSPENSION;ORAL064114-001Apr 28, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Yung Shin PharmCEFACLORcefaclorFOR SUSPENSION;ORAL065412-004Feb 17, 2012ABRXNoYes► Subscribe► Subscribe► Subscribe► Subscribe
World GenCEFACLORcefaclorTABLET, EXTENDED RELEASE;ORAL065057-001Jan 5, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Ivax Sub Teva PharmsCEFACLORcefaclorFOR SUSPENSION;ORAL064070-001Apr 28, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LillyCECLORcefaclorCAPSULE;ORAL050521-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Yung Shin PharmCEFACLORcefaclorFOR SUSPENSION;ORAL065412-002Feb 17, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Facta FarmaCEFACLORcefaclorFOR SUSPENSION;ORAL062206-003Apr 20, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Ranbaxy Labs LtdRANICLORcefaclorTABLET, CHEWABLE;ORAL065092-002Dec 22, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Fish and Richardson
Daiichi Sankyo
Farmers Insurance
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: